Inspection Record

Atlas Pharma Inc. — Health Canada Inspection Findings

Health CanadaInspected 2021-01-18 6 findingsComputer system validationOther quality systemEquipment and facilityDeviation, CAPA, and investigationRegulatory reporting and change control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

2Other quality system

The availability or the content of the authentic certificate of analysis was inadequate.

3Equipment and facility

The establishment and/or the maintenance of a data governance plan was inadequate.

4Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate. The availability or the content of the authentic certificate of analysis was inadequate.

5Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

6Other quality system

The receipt, preparation, and/or handling of reagents and culture media was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2021-01-18. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Atlas Pharma Inc. findings history — including this company's other documents Health Canada documents, 2021 Go to Findings search